tiletamine hydrochloride has been researched along with Astrocytoma, Grade IV in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badr, CE; Dumbuya, H; Tannous, BA; Tjon-Kon-Fat, LA; Van Hoppe, S | 1 |
| Fukushima, T; Kataoka, H; Kawaguchi, M; Takeshima, H; Tanaka, H; Umezawa, K; Yorita, K | 1 |
2 other study(ies) available for tiletamine hydrochloride and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Targeting cancer cells with the natural compound obtusaquinone.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cinnamates; Cyclohexanones; DNA Damage; Down-Regulation; Flow Cytometry; Gene Expression Regulation, Neoplastic; Glioblastoma; Glutathione; Humans; Immunoblotting; Immunoprecipitation; Mice; Neoplasms; Neoplasms, Experimental; Oxidative Stress; Reactive Oxygen Species; Treatment Outcome; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2013 |
Antitumor effect of dehydroxymethylepoxyquinomicin, a small molecule inhibitor of nuclear factor-κB, on glioblastoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Brain Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cyclohexanones; Glioblastoma; Humans; Male; Mice; Mice, Nude; NF-kappa B; Transcription Factor RelA; Xenograft Model Antitumor Assays | 2012 |